EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY-NC 3.0

ERBB2 Exon 20 Mutation-Guided Trastuzumab Deruxtecan Therapy in Metastatic Lung Adenocarcinoma with Low HER2 Expression: A Case Report

Zhao-Feng Gao, Xu Wen, Jia-Qi Yu, Jun Zhang, Qian-Yu Chen, Xin-Wei Zhou, Xue-Song He iD, Peng-Li Wang

OncoTargets and Therapy · 2026-11 · Volume 19 · 1-10

DOI: 10.2147/ott.s653854 ↗

Kurz gefasst

Fallbericht in der Zeitschrift OncoTargets and Therapy, 2026-11. Verfasst von Zhao-Feng Gao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, 314000, People's Republic of China. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

HER2 mutationcase reportlung adenocarcinomatargeted therapytrastuzumab deruxtecan

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, 314000, People's Republic of China.
  • Jiaxing University Master Degree Cultivation Base, Zhejiang Chinese Medical University, Hangzhou, Zhejiang Province, 310053, People's Republic of China.
  • Department of Cardiothoracic Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, 314000, People's Republic of China.
  • The School of Public Administration, Southwestern University of Finance and Economics, Chengdu, 611130, People's Republic of China.
  • Department of Vascular Surgery, The Second Affiliated Hospital of Jiaxing University, Jiaxing, Zhejiang, 314000, People's Republic of China.

ORCID-Profile: Xue-Song He

Zitieren

APA

Gao, Z. F., Wen, X., Yu, J. Q., Zhang, J., Chen, Q. Y., Zhou, X. W., He, X. S., & Wang, P. L. (2026). ERBB2 Exon 20 Mutation-Guided Trastuzumab Deruxtecan Therapy in Metastatic Lung Adenocarcinoma with Low HER2 Expression: A Case Report. OncoTargets and Therapy, Volume 19, 1-10. https://doi.org/10.2147/ott.s653854

Vancouver

Gao ZF, Wen X, Yu JQ, Zhang J, Chen QY, Zhou XW, et al. ERBB2 Exon 20 Mutation-Guided Trastuzumab Deruxtecan Therapy in Metastatic Lung Adenocarcinoma with Low HER2 Expression: A Case Report. OncoTargets and Therapy. 2026;Volume 19:1-10. doi:10.2147/ott.s653854

BibTeX
@article{Gao2026,
  author = {Gao, Zhao-Feng and Wen, Xu and Yu, Jia-Qi and Zhang, Jun and Chen, Qian-Yu and Zhou, Xin-Wei and He, Xue-Song and Wang, Peng-Li},
  title = {ERBB2 Exon 20 Mutation-Guided Trastuzumab Deruxtecan Therapy in Metastatic Lung Adenocarcinoma with Low HER2 Expression: A Case Report},
  journal = {OncoTargets and Therapy},
  year = {2026},
  volume = {Volume 19},
  pages = {1--10},
  doi = {10.2147/ott.s653854}
}
Kostenlos starten →